Shama Khan to Drug Discovery
This is a "connection" page, showing publications Shama Khan has written about Drug Discovery.
Connection Strength
0,709
-
Structure-based identification of novel inhibitors targeting the enoyl-ACP reductase enzyme of Acinetobacter baumannii. Sci Rep. 2023 12 04; 13(1):21331.
Score: 0,221
-
In-silico identification of potential inhibitors against FabI protein in Klebsiella pneumoniae. J Biomol Struct Dyn. 2024 Feb-Mar; 42(3):1506-1517.
Score: 0,212
-
Covalent Inhibition in Drug Discovery: Filling the Void in Literature. Curr Top Med Chem. 2018; 18(13):1135-1145.
Score: 0,147
-
Quorum Sensing and Biofilm Disrupting Potential of Imidazole Derivatives in Chromobacterium violaceum Using Antimicrobial and Drug Discovery Approaches. Braz J Microbiol. 2022 Jun; 53(2):565-582.
Score: 0,049
-
Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling. Molecules. 2019 Aug 28; 24(17).
Score: 0,041
-
An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy. Expert Opin Drug Discov. 2018 10; 13(10):903-918.
Score: 0,039